Table 1 Patient characteristics and intraoperative data
|  | Group P (n = 27) | Group PR (n = 27) | P-value |
|---|---|---|---|
Age (years) | 31 [27–42] | 33 [23–38] | 0.808 |
Sex (male/female), n (%) | 11 (40.7)/16 (59.3) | 15 (55.6)/12 (44.4) | 0.276 |
Height (cm) | 157.2 ± 10.9 | 163.1 ± 9.2 | 0.035 |
Weight (kg) | 55.0 ± 16.4 | 64.3 ± 16.7 | 0.047 |
BMI (kg/m2) | 22.0 ± 5.3 | 23.9 ± 4.9 | 0.199 |
ASA physical status (II/III), n (%) | 4 (14.8)/23 (85.2) | 6 (22.2)/21 (77.8) | 0.484 |
Use of antiepileptic drugs, n (%) | 13 (48.1) | 17 (63) | 0.273 |
Preoperative QoR-15 K score | 103.2 ± 15.0 | 109.6 ± 15.3 | 0.128 |
Duration of surgery (min) | 150 [98–225] | 180 [113–215] | 0.359 |
Duration of anesthesia (min) | 175 [114–243] | 190 [128–228] | 0.50 |
Duration of remimazolam infusion (min) |  | 64.7 ± 25.0 |  |
Total amount of propofol (mg) | 950 [700–1550] | 800 [500–1090] |  |
Total amount of remimazolam (mg) |  | 60.0 [32.5–70.0] |  |
Total amount of remifentanil (mcg)/Weight (kg) | 10.6 [6.70–13.1] | 10.7 [8.37–14.3] | 0.268 |
Need for vasopressors, n (%) | 5 (18.5) | 4 (14.8) | 0.715 |